Related Experiment Video
Updated: May 21, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Published on: April 28, 2019
Fluid management for dengue in children
1Department of Dengue Hemorrhagic Fever, Children’s Hospital No. 1, Ho Chi Minh City, Viet Nam. hungdhf@hcm.fpt.vn
Insights
Isotonic crystalloid solutions effectively treat most Dengue Shock Syndrome (DSS) patients. For severe cases, medium-molecular-weight colloid solutions offer optimal plasma volume support with fewer adverse events.
Area of Science:
- Infectious Diseases
- Public Health
- Pediatrics
Background:
- Dengue fever is a global health concern, with Dengue Shock Syndrome (DSS) posing a critical threat.
- Prompt treatment is vital for DSS, as it can be fatal within 12-24 hours.
- Intravenous fluid therapy is essential for DSS patients and some non-shocked dengue patients.
Purpose of the Study:
- To summarize clinical data comparing fluid resuscitation regimens in children with severe dengue.
- To evaluate the efficacy and safety of different fluid solutions for Dengue Shock Syndrome.
Main Methods:
- Review of key clinical data on fluid management in severe dengue.
- Comparison of crystalloid and colloid solutions for plasma volume support.
Main Results:
- Most Dengue Shock Syndrome patients can be successfully treated with isotonic crystalloid solutions.
- Colloid solutions may be used in severe cases but carry higher risks.
- Medium-molecular-weight colloids are optimal if colloids are necessary, balancing efficacy and safety.
Conclusions:
- Isotonic crystalloids are generally sufficient for treating Dengue Shock Syndrome.
- Careful selection of colloid solutions is crucial when required, favoring medium-molecular-weight preparations.
- Further research is needed on early colloid administration and optimal colloid choice for DSS resuscitation.
Abstract:
Dengue is a serious public health problem worldwide. Dengue shock syndrome (DSS), the severe form of dengue fever, can cause death within 12-24 hours if appropriate treatment is not promptly administered. For patients with DSS and the 30% of non-shocked dengue patients who require intravenous fluid therapy, a range of solutions is available for plasma volume support. Crystalloid solutions, such as normal 0·9% saline or Ringer's lactate, are the ones most commonly used. In severe cases, colloid solutions may be administered for their greater osmotic effect, although they carry a greater risk of adverse events. This paper summarises the key clinical data, comparing fluid regimens in children with severe dengue, and concludes that the majority of patients with DSS can be treated successfully with isotonic crystalloid solutions. If a colloid is thought necessary, a medium-molecular-weight preparation that combines good initial plasma volume support with good intravascular persistence and an acceptable side-effect profile is optimal. Further research should aim to determine whether there are benefits to early treatment with colloids, and which colloid solution is most effective for resuscitation of DSS patients.
More Related Videos
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Diabetes Insipidus II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Methods of reducing fever
Pharmacological Methods of Reducing Fever:

